CHINA PHARMA HOLDINGS, INC. Impairment of Intangible Assets (Excluding Goodwill)
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Impairment of Intangible Assets (Excluding Goodwill) of $1.81 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2023-03-30
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2016-12-31 was $2.49M, a 2286.47% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2016-09-30 was $644.70K.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2015-12-31 was $104.54K.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2015-09-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2022 was $1.81M.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2016 was $3.96M, a 3689.93% increase from fiscal 2015.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2015 was $104.54K.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2014 was $0.00.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $1.81M 10-K · filed 2023-03-30 | |||
| 2016-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $3.14M derived: sum of 2 quarters · filed 2017-03-31 | $3.96M 10-K · filed 2017-03-31 | |
| 2016-09-30 | $644.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.47M 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $822.54K 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | $104.54K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $104.54K derived: sum of 2 quarters · filed 2017-03-31 | $104.54K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 | |||
| 2012-12-31 | $593.10K 10-K · filed 2013-03-14 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |